Aprea Therapeutics, Inc. (APRE)
SG&A Expenses
$1.57M
Quarterly · Period ending: · USD
APRE SG&A Expenses
Latest reported$1.57Mperiod ending
Latest reported$1.57Mperiod ending
APRE Quarterly SG&A Expenses ($623.70K → $1.57M)
Quarterly SG&A Expenses
High-resolution chart · PNG
APRE sg&a expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expenses (USD) |
|---|---|
| 1,570,138 | |
| 1,813,817 | |
| 1,637,591 | |
| 1,480,319 | |
| 1,593,671 | |
| 1,764,979 | |
| 1,072,776 | |
| 1,605,238 | |
| 1,850,819 | |
| 1,929,866 | |
| 1,643,315 | |
| 1,719,715 | |
| 1,698,712 | |
| 3,365,961 | |
| 2,120,222 | |
| 3,082,618 | |
| 15,633,738 | |
| 3,985,298 | |
| 3,366,525 | |
| 3,414,795 | |
| 3,343,325 | |
| 3,425,833 | |
| 4,895,323 | |
| 3,473,210 | |
| 3,786,886 | |
| 2,776,468 | |
| 3,937,765 | |
| 2,307,946 | |
| 1,618,589 | |
| 729,326 | |
| 504,449 | |
| 623,702 |